BGG World and its subsidiary, Algae Health Sciences (AHS), has announced the completion of a major capacity expansion at its glass tube photobioreactor microalgae farm. The expansion doubles the company’s astaxanthin production capacity and will allow for fulfilment of customers’ demands for the next three to five years, after which adjacent land will be utilised for future expansions. The company completed this expansion during the last 18 months despite many challenges presented by the worldwide coronavirus epidemic.
“At BGG, we never want to leave any customer with unfulfilled or late orders, and we rarely do,” said Chunhua Li, Chairman & Founder of BGG World. “This expansion of capacity for our flagship AstaZine natural astaxanthin product line should keep our customers happy and their orders filled into the second half of this decade.”
BGG Americas and Algae Health Sciences CEO Bob Capelli added: “We not only continue to lead the astaxanthin market with ongoing clinical research, but we back that up with capacity expansions to consistently stay ahead of demand. Having worked in the astaxanthin business for the last twenty years, I’ve never seen any producer react as quickly to market needs.”
